Release Date: 11/02/16 10:45 Summary: Half Year Report and Accounts Price Sensitive: Yes Download Document 1.35MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%